Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02611063
Title Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stefanie Sarantopoulos, MD, PhD.
Indications

hematologic cancer

Therapies

Fostamatinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.